ARCHETYPE
Live / Allowed — Third extension granted (statement of use) (as of 24 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Sept 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98178209
- Mark type
- Word mark
- Filed
- 13 Sept 2023
- Published for opposition
- 10 Dec 2024
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for a wide variety of human diseases
- Class 009 — Scientific and electric apparatus: Downloadable computer software for data analysis in the field of drug discovery
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; drug discovery services; research and development of pharmaceuticals utilizing a proprietary drug discovery platform; platform as a service (PAAS) featuring computer software platforms for data analysis in the field of drug discovery
- Class 045 — Legal and security services: Licensing of intellectual property
Owner
- Archetype Therapeutics, Inc., Winchester, MA, US
- Archetype Therapeutics, Inc., Winchester, MA, US
Prosecution history
- 25 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2026 — SOU EXTENSION 3 GRANTED
- 24 Jun 2026 — SOU EXTENSION 3 FILED
- 24 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2026 — SOU EXTENSION 2 GRANTED
- 09 Jan 2026 — SOU EXTENSION 2 FILED
- 09 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jul 2025 — SOU EXTENSION 1 GRANTED
- 29 Jul 2025 — SOU EXTENSION 1 FILED
- 29 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION